Client company Vestaron adds Susan Altschuller, Ph.D., MBA, to its board of directors as the Chair of the Audit Committee

Vestaron is proud to announce that Susan Altschuller, Ph.D., MBA, has joined its board of directors as the Chair of the Audit Committee.

Dr. Altschuller brings to Vestaron 20 years of financial management, investor relations, and business planning experience with leading pharmaceutical and biotechnology companies. She currently serves as the Chief Financial Officer of ImmunoGen, a biotechnology company developing the next generation of antibody-drug conjugates for cancer patients. Prior to ImmunoGen, Dr. Altschuller held roles of increasing responsibility with a series of biotech firms, including Biogen, Bioverativ, and Alexion.

Read more on the Vestaron website.